Consistent with this was the attenuated activity levels of IL-2 and TGF-β signaling pathways in CD4 Treg cells of SLE (Supplementary Fig. 8b), affording a diminished capacity to maintain immune tolerance. This evidence concerns the gene CD4 and systemic lupus erythematosus.